Improving Access to Care for Veterans With Memory Loss
This study evaluates a care delivery protocol to improve access to care for Veterans with Alzheimer's Disease and Related Disorders (ADRD). A randomized controlled trial will enroll Veterans with mild cognitive impairment or early dementia at VA Pittsburgh. The ADRD care delivery protocol integrates telehealth, advance
| Condition(s) | Alzheimer Disease |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This study evaluates a care delivery protocol to improve access to care for Veterans with Alzheimer's Disease and Related Disorders (ADRD). A randomized controlled trial will enroll Veterans with mild cognitive impairment or early dementia at VA Pittsburgh. The ADRD care delivery protocol integrates telehealth, advanced diagnostics, and streamlined workflows to expedite screening for eligibility for amyloid targeting therapies. |
| Who can participate | Inclusion Criteria: * Diagnosis of mild cognitive impairment or mild dementia due to suspected or confirmed AD with a 5 minute telephone MoCA score \>7 * Meets VA MUE inclusion/exclusion criteria for mAb therapy for AD * Enrolled in VA care * Lives in a home setting (i.e., not in an institutional setting such as a nursing home, Community Living Center, or hospital) * Has a working telephone * 18 years and older * Able to communicate in English * Willing to give informed consent. Exclusion Criteria: * None |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | VA Pittsburgh Healthcare System |
| Locations | Pittsburgh, Pennsylvania, United States |
| Start date | 2025-10-29 |
| NCT ID | NCT07117162 |
| Official listing | https://clinicaltrials.gov/study/NCT07117162 |